shares in zur rose group ag traded higher after the swiss onlinepharmacy company said fourthquarter revenue rose and backed its midterm targets the companys revenue for the quarter rose 14 to 4666 million swiss francs 5094 million external revenuewhich factors in online revenue made by pharmacies it suppliesrose 52 to chf5433 million zur rose said it had 124 million active customers in 2021 up 18 from the previous year revenue growth was supported by strong momentum in germany the companys largest market thanks mainly to nonprescription drugs and healthcare products zur rose said it still assumes that the rollout of mandatory electronic prescriptions in germanywhich was delayed last monthwill take place this year based on this assumption it backed its mediumterm earnings before interest tax depreciation and amortization margin target of about 8